Trace elements and rheumatoid arthritis (RA)--pathogenetic and therapeutic aspects.
Rheumatoid arthritis is characterized by increased activity of macrophages which produce toxic forms of oxygen. Such oxygen has been suggested as mediator also of rheumatoid inflammation. Gold accumulates in lysosomes of the macrophages and stabilizes lysosomal and other cell membranes leading to reduced liberation of toxic oxygen. Intracellular production of metallothionein can be induced. Zinc in high doses parenterally can immobilize macrophages and also induce metallothionein-like proteins. Copper and zinc are components of SOD which detoxifies oxygen, and copper-thiolate complexes are reported to be anti-inflammatory. The therapeutic effect of penicillamine and other thiols like aurothiomalate may also be related to an anti-oxidative action. Therapeutic induction of increased intracellular levels of glutathione or administration of selenium in such a form that it incorporates into glutathione-peroxidase and increases the efficacy of the enzyme may lead to accelerated metabolism of toxic oxygen.
D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D002614:Chelating Agents / Q000627:therapeutic use; D003300:Copper / Q000627:therapeutic use*; D006046:Gold / Q000627:therapeutic use*; D006801:Humans; D008670:Metals / Q000502:physiology; D012643:Selenium / Q000627:therapeutic use; D013438:Sulfhydryl Compounds / Q000627:therapeutic use; D013481:Superoxides / Q000378:metabolism; D015032:Zinc / Q000627:therapeutic use*
D002614:Chelating Agents; D008670:Metals; D013438:Sulfhydryl Compounds; D013481:Superoxides; D006046:Gold; D003300:Copper; D012643:Selenium; D015032:Zinc